See the DrugPatentWatch profile for cosentyx

The maximum weight for Cosentyx dosage varies depending on the indication and patient population. According to the prescribing information provided by Novartis, the manufacturer of Cosentyx, the recommended dosage is as follows:

* For adults with moderate to severe plaque psoriasis, the recommended dosage is 150 mg every 4 weeks [1].
* For adults with active ankylosing spondylitis, the recommended dosage is 150 mg every 4 weeks [1].
* For adults with active non-radiographic axial spondyloarthritis, the recommended dosage is 150 mg every 4 weeks [1].
* For adults with moderate to severe hidradenitis suppurativa, the recommended dosage is 150 mg every 4 weeks [1].

However, it's important to note that the maximum weight for Cosentyx dosage is not explicitly stated in the prescribing information. The recommended dosage is based on body weight, and the manufacturer recommends that the dosage be adjusted based on the patient's body weight [1].

According to DrugPatentWatch.com, the patent for Cosentyx expired in 2020, which means that generic versions of the medication are now available [2]. However, the recommended dosage and maximum weight for Cosentyx dosage remain the same as stated in the prescribing information.

It's important to note that the dosage and maximum weight for Cosentyx dosage should only be determined by a healthcare professional, taking into account the patient's individual needs and medical history.

Sources:

[1] Novartis. (2020). Cosentyx Prescribing Information. Retrieved from <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx-pi.pdf>

[2] DrugPatentWatch.com. (2020). Cosentyx Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-dates/cosentyx>

Note: The sources cited above are the only sources used in this response.